Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2005
09/01/2005US20050192269 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
09/01/2005US20050191643 Cyanine compounds and their application as quenching compounds
09/01/2005US20050191616 Membrane and 1,2-dipalmitoyl-sn-glycero-3-phospho-N-(2-hydroxymethyl)-3,5-divinylbenzamide; DNA sequencing
09/01/2005DE10247680B4 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase New bicyclic inhibitors of hormone sensitive lipase
09/01/2005DE102004006893A1 Verfahren zur Herstellung von Process for the preparation of 1[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin
09/01/2005DE102004004973A1 New 7-phenylamino-quinolone or 1,8-naphthyridone derivatives, useful e.g. for treating type II diabetes or arteriosclerosis, are inhibitors of glycogen phosphorylase
09/01/2005CA2557433A1 Quinazoline derivatives and therapeutic use thereof
09/01/2005CA2557158A1 Prophylactic antimigraine agents
09/01/2005CA2556589A1 4-substituted piperidine derivatives
09/01/2005CA2556480A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005CA2556268A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2556263A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2555554A1 Chemical process
09/01/2005CA2555402A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005CA2555272A1 Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2555133A1 Substituted quinoline compounds
09/01/2005CA2555073A1 Amino heterocyclic modulators of chemokine receptor activity
09/01/2005CA2555071A1 Histamine-3 receptor modulators
09/01/2005CA2554894A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2554774A1 Novel heterocyclic compound
09/01/2005CA2554090A1 Triazole derivatives which inhibit vasopressin antagonistic activity
09/01/2005CA2548218A1 Imidazole-based hmg-coa reductase inhibitors
09/01/2005CA2498966A1 Novel pyrazole analogs acting on cannabinoid receptors
08/2005
08/31/2005EP1568698A1 Pyrrole-derivatives as factor Xa inhibitors
08/31/2005EP1568695A1 3,4-Dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1568691A1 Erythropoietin production accelerator
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1567597A1 Process for the production of meso-substituted cyanine dyes
08/31/2005EP1567518A2 Oxime ester photoinitiators with heteroaromatic groups
08/31/2005EP1567517A1 Anilinopyrazole derivatives useful for the treatment of diabetes
08/31/2005EP1567507A1 1,2,3- triazole amide derivatives as cytokine inhibitors
08/31/2005EP1567506A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
08/31/2005EP1567504A1 Antibacterial agents
08/31/2005EP1567503A1 Pyrazole derivatives useful as cox-i inhibitors
08/31/2005EP1567502A1 Substituted dihydrophenanthridinesul fonamides
08/31/2005EP1567500A1 Resolution of mefloquine with o,o-di-p-aroyltartaric acid
08/31/2005EP1567496A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
08/31/2005EP1567494A1 Methods for preparing phenylalkyne derivatives
08/31/2005EP1567493A1 Phenyl substituted piperidine compounds for use as ppar activators
08/31/2005EP1567489A1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa
08/31/2005EP1567488A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
08/31/2005EP1567487A2 Open chain prolyl urea-related modulators of androgen receptor function
08/31/2005EP1567157A1 Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases
08/31/2005EP1567151A1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer
08/31/2005EP1478437B1 Acc inhibitors
08/31/2005EP1395576B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
08/31/2005EP1366038B1 Cdk-1 inhibitor oxindoles and the application thereof in therapeutics
08/31/2005EP1363901A4 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles
08/31/2005EP1289963B1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1237875B1 Substituted imidazole neuropeptide y y5 receptor antagonists
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662523A Novel process
08/31/2005CN1662522A Novel compounds, their use and preparation
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662503A Process for preparation of 2-pyridone compounds substituted with phenoxy group
08/31/2005CN1662502A Cyanoguanidine produgs
08/31/2005CN1662501A Cyanoguanidine prodrugs
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662488A Method for making aryl hydrazines and substituted indoles
08/31/2005CN1662239A Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660838A Method for preparing and purifying laevogyrate gatifloxacin
08/31/2005CN1660821A Oxodiethylenediamine derivative and light stabilized composition
08/31/2005CN1660820A 3, 4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660812A New medical salt and preparation in group of carbostyril mandelate and preparing method
08/31/2005CN1660811A Compound of 1, 4-substituted benzenes and preparing method and application
08/31/2005CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
08/31/2005CN1216947C Reactive dye compounds
08/31/2005CN1216872C Quinazoline derivatives and pharmaceutical applications thereof
08/31/2005CN1216867C 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors
08/31/2005CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/30/2005US6936718 Reacting with acid mixed with solvent; salt formation
08/30/2005US6936717 Tinuvin P-hindred amine light stabilizer and derivatives thereof
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936626 Retinoic acid mimetic anilides
08/30/2005US6936620 Nitrogen compounds such as 5-(4-(Benzyloxy)benzyl)-5-methyl-2, 4,6(1H,3H,5H)-pyrimidinetrione, used as enzyme inhibitors, used as antiinflammatory agents
08/30/2005US6936619 Quinazolinone compounds useful in therapy
08/30/2005US6936616 Pyrimidine matrix metalloproteinase inhibitors
08/30/2005US6936615 Heteroaryl derivatives and their use as medicaments
08/30/2005US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936610 Heterocyclic derivatives
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/25/2005WO2005077944A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005WO2005077939A1 Substituted benzimidazoles and their use for inducing apoptosis
08/25/2005WO2005077938A1 Vanilloid receptor ligands and their use in treatments
08/25/2005WO2005077937A1 Substituted hydroxamic acid derivatives as tnf inhibitors
1 ... 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 ... 1080